The store will not work correctly when cookies are disabled.
4-[6-Amino-5-(4-fluorophenyl)pyridin-3-yl]benzoic acid
ID: ALA4757382
PubChem CID: 162657210
Max Phase: Preclinical
Molecular Formula: C18H13FN2O2
Molecular Weight: 308.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ncc(-c2ccc(C(=O)O)cc2)cc1-c1ccc(F)cc1
Standard InChI: InChI=1S/C18H13FN2O2/c19-15-7-5-12(6-8-15)16-9-14(10-21-17(16)20)11-1-3-13(4-2-11)18(22)23/h1-10H,(H2,20,21)(H,22,23)
Standard InChI Key: XGTIBSVSXRGZAU-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
40.3835 -18.2299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3824 -19.0495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0904 -19.4584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8001 -19.0490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7972 -18.2263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0886 -17.8211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.5049 -19.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5049 -20.2740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2124 -20.6814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9204 -20.2717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9165 -19.4503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2084 -19.0465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5034 -17.8151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.6762 -19.4578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9686 -19.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2610 -19.4543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2599 -20.2723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9723 -20.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6769 -20.2716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5494 -20.6829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8415 -20.2747 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.5498 -21.5001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.6293 -20.6782 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 7 1 0
5 13 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
2 14 1 0
20 21 1 0
20 22 2 0
17 20 1 0
10 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 308.31 | Molecular Weight (Monoisotopic): 308.0961 | AlogP: 3.84 | #Rotatable Bonds: 3 |
Polar Surface Area: 76.21 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.02 | CX Basic pKa: 7.03 | CX LogP: 1.92 | CX LogD: 1.41 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.77 | Np Likeness Score: -0.59 |
References
1. Dow RL,Ammirati M,Bagley SW,Bhattacharya SK,Buckbinder L,Cortes C,El-Kattan AF,Ford K,Freeman GB,Guimarães CRW,Liu S,Niosi M,Skoura A,Tess D. (2018) 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety., 61 (7): [PMID:29570292] [10.1021/acs.jmedchem.8b00152] |